Drug & Gene Delivery Devices Market Size & Forecast to 2032

The global drug and gene delivery devices market is evolving rapidly, influenced by innovation in materials, device engineering, and shifting demands in clinical practice. As patient needs and healthcare models change, senior decision-makers are tasked with adapting commercialization, integration, and supply strategies to maintain relevance and resilience across the industry.

Market Snapshot: Drug and Gene Delivery Devices Market Overview

The drug and gene delivery devices market expanded from USD 5.32 billion in 2025 to USD 5.92 billion in 2026, with an anticipated CAGR of 11.01%. This growth trajectory is expected to carry the sector to USD 11.06 billion by 2032. A combination of advanced delivery technologies, ongoing progress in material science, and expanding precision medicine initiatives are central drivers. Additional tailwinds come from the increased adoption of home healthcare, the growing presence of complex biologic therapies, and regulatory frameworks adapting to novel device requirements. The result is a highly dynamic marketplace with evolving commercialization pathways and manufacturing strategies.

Scope & Segmentation

Technology Classes: Hydrogels, nanoparticle carriers, liposomal formulations, and advanced polymer-based constructs deliver targeted, precise, and stable administration of therapeutics.
Device Types: Auto injectors, infusion pumps, pen injectors, needle-free systems, and syringes represent a range of platforms, each demanding user-centric design and operational reliability.
Molecule Categories: Biologics, gene therapies—including both viral and non-viral vectors—and small molecules require delivery systems that ensure molecular integrity and biodefense throughout administration.
Care Settings: Clinics, hospitals, home healthcare, and research environments each present unique requirements for usability, training, and ergonomic features.
Application Profiles: Controlled release, smart delivery, targeted deployment, and sustained release technologies support improved therapeutic outcomes and reduced patient burden.
Therapeutic Areas: Oncology, infectious diseases, cardiovascular, and diabetes benefit from differentiated delivery strategies designed to meet clinical and regulatory demands.
Regional Markets: Americas, Europe Middle East & Africa (EMEA), and Asia-Pacific shape commercialization potential and supply chain models in response to diverse regulatory and manufacturing landscapes.

Key Takeaways

Delivery engineering innovation and the adoption of next-generation materials enable outpatient and home-based therapeutic administration, improving patient adherence and broadening market reach.
Integrated collaboration between drug, gene, and device design processes is critical to meeting biocompatibility requirements and changing regulatory standards.
Emphasis on human factors engineering and comprehensive usability testing ensures that devices are suitable for a wide range of healthcare environments, supporting successful adoption and clinical integration.
Strategic partnerships among pharmaceutical manufacturers, device developers, and contract manufacturing organizations streamline product launch timelines and limit technology integration risks.
Digital advancements such as sensor technologies and data integration tools are generating actionable insights, supporting real-time patient monitoring, and improving therapeutic management.

Tariff Impact

Recently implemented tariff policies and changes in global trade have brought new complexity to drug and gene delivery device manufacturing. Increases in import duties on specialty materials are influencing decisions around supplier diversification, nearshoring, and regional partnership investments. While these shifts introduce temporary supply chain volatility, they also encourage the development of vertically integrated, resilient supply networks tailored to the distinct needs of each region.

Methodology & Data Sources

The findings in this report are grounded in structured industry expert interviews, usability test data, technical literature review, and analysis of regulatory documents. The research employed thematic synthesis, scenario modelling, and mappings of manufacturer capabilities, with all key assumptions cross-validated for consistency and relevance.

Why This Report Matters

Empowers executive teams to adjust product strategies through actionable, segment-targeted insights that align device platforms to evolving channel demands.
Aids risk management by identifying early-warning indicators for policy or regulatory shift, facilitating proactive responses in global supply and commercialization planning.
Enables senior leaders to foster high-impact partnerships, expedite evidence-building, and make informed capital allocation decisions for sustainable competitive positioning.

Conclusion

A strategic approach to integrating technology, supply chain solutions, and commercialization planning is vital for success in the drug and gene delivery devices market. Organizations that align capabilities across functions and regions will be best positioned for enduring adoption and value generation throughout global healthcare systems.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Drug & Gene Delivery Devices Market, by Technology

8.1. Hydrogel Based
8.2. Liposomal
8.3. Nanoparticle
8.4. Polymer Based

9. Drug & Gene Delivery Devices Market, by Device Type

9.1. Auto Injector
9.2. Infusion Pump
9.3. Needle Free Injector
9.4. Pen Injector
9.5. Syringe

10. Drug & Gene Delivery Devices Market, by Molecule Type

10.1. Biologic
10.1.1. Monoclonal Antibody
10.1.2. Peptide
10.1.3. Recombinant Protein
10.2. Gene Therapy
10.2.1. Non Viral
10.2.1.1. Lipid Based
10.2.1.2. Polymer Based
10.2.2. Viral Vector
10.2.2.1. Adenoviral
10.2.2.2. Lentiviral
10.2.2.3. Retroviral
10.3. Small Molecule

11. Drug & Gene Delivery Devices Market, by End User

11.1. Clinics
11.2. Home Healthcare
11.3. Hospitals
11.4. Research Laboratories

12. Drug & Gene Delivery Devices Market, by Application

12.1. Controlled Release
12.2. Smart Delivery
12.3. Sustained Release
12.4. Targeted Delivery

13. Drug & Gene Delivery Devices Market, by Therapeutic Area

13.1. Cardiovascular
13.2. Diabetes
13.3. Infectious Diseases
13.4. Oncology

14. Drug & Gene Delivery Devices Market, by Region

14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific

15. Drug & Gene Delivery Devices Market, by Group

15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO

16. Drug & Gene Delivery Devices Market, by Country

16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea

17. United States Drug & Gene Delivery Devices Market
18. China Drug & Gene Delivery Devices Market

19. Competitive Landscape

19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Amgen Inc.
19.6. AstraZeneca plc
19.7. B. Braun Melsungen AG
19.8. Baxter International Inc.
19.9. Bayer AG
19.10. Becton, Dickinson & Company
19.11. Catalent, Inc.
19.12. Epeius Biotechnologies Corporation
19.13. F. Hoffmann-La Roche Ltd.
19.14. Fresenius Kabi AG
19.15. Gerresheimer AG
19.16. Johnson & Johnson Services, Inc.
19.17. Lonza Group AG
19.18. Medtronic plc
19.19. Nipro Corporation
19.20. Novartis AG
19.21. Sartorius AG
19.22. Shanghai Sunway Biotech Co., Ltd.
19.23. SHL Medical AG
19.24. SiBiono GeneTech Co., Ltd.
19.25. Stevanato Group S.p.A.
19.26. Terumo Corporation
19.27. UniQure N.V.
19.28. West Pharmaceutical Services, Inc.
19.29. Ypsomed Holding AG

List of Figures

FIGURE 1. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HYDROGEL BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HYDROGEL BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HYDROGEL BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LIPOSOMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LIPOSOMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LIPOSOMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NANOPARTICLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NANOPARTICLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NANOPARTICLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY POLYMER BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY POLYMER BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY POLYMER BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY AUTO INJECTOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY AUTO INJECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NEEDLE FREE INJECTOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NEEDLE FREE INJECTOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NEEDLE FREE INJECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SYRINGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PEPTIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PEPTIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RECOMBINANT PROTEIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RECOMBINANT PROTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LIPID BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LIPID BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LIPID BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY POLYMER BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY POLYMER BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY POLYMER BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ADENOVIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ADENOVIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ADENOVIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LENTIVIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LENTIVIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LENTIVIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RETROVIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RETROVIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RETROVIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CONTROLLED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CONTROLLED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SMART DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SMART DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SMART DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SUSTAINED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SUSTAINED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TARGETED DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TARGETED DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 159. EUROPE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. EUROPE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 161. EUROPE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 162. EUROPE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 163. EUROPE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 164. EUROPE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 165. EUROPE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 166. EUROPE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 167. EUROPE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. EUROPE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. EUROPE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 181. AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 183. AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 184. AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 185. AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 186. AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 187. AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 188. AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 189. AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. ASEAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. ASEAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 206. ASEAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 207. ASEAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 208. ASEAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 209. ASEAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 210. ASEAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 211. ASEAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 212. ASEAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. ASEAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 214. ASEAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 215. GCC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. GCC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 217. GCC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 218. GCC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 219. GCC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 220. GCC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 221. GCC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 222. GCC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 223. GCC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. GCC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. GCC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 237. BRICS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. BRICS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 239. BRICS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 240. BRICS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 241. BRICS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 242. BRICS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 243. BRICS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 244. BRICS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 245. BRICS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. BRICS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 247. BRICS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 248. G7 DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 249. G7 DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 250. G7 DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 251. G7 DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 252. G7 DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 253. G7 DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 254. G7 DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 255. G7 DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 256. G7 DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. G7 DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 258. G7 DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 259. NATO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 260. NATO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 261. NATO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 262. NATO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 263. NATO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 264. NATO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 265. NATO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 266. NATO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 267. NATO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 268. NATO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 269. NATO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 282. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 283. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 284. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 285. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 286. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
TABLE 287. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 288. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON VIRAL, 2018-2032 (USD MILLION)
TABLE 289. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 290. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 291. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 292. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Drug & Gene Delivery Devices market report include:

Amgen Inc.
AstraZeneca plc
B. Braun Melsungen AG
Baxter International Inc.
Bayer AG
Becton, Dickinson & Company
Catalent, Inc.
Epeius Biotechnologies Corporation
F. Hoffmann-La Roche Ltd.
Fresenius Kabi AG
Gerresheimer AG
Johnson & Johnson Services, Inc.
Lonza Group AG
Medtronic plc
Nipro Corporation
Novartis AG
Sartorius AG
Shanghai Sunway Biotech Co., Ltd.
SHL Medical AG
SiBiono GeneTech Co., Ltd.
Stevanato Group S.p.A.
Terumo Corporation
UniQure N.V.
West Pharmaceutical Services, Inc.
Ypsomed Holding AG

Table Information

Report Attribute	Details
No. of Pages	187
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 5.92 Billion
Forecasted Market Value ( USD ) by 2032	$ 11.06 Billion
Compound Annual Growth Rate	11.0%
Regions Covered	Global
No. of Companies Mentioned	26

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3480EUR$3,939USD£3,035GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3754EUR$4,249USD£3,273GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5088EUR$5,759USD£4,437GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6157EUR$6,969USD£5,369GBP

Drug & Gene Delivery Devices Market - Global Forecast 2026-2032

Market Snapshot: Drug and Gene Delivery Devices Market Overview

Scope & Segmentation

Key Takeaways

Tariff Impact

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot: Drug and Gene Delivery Devices Market Overview

Scope & Segmentation

Key Takeaways

Tariff Impact

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Novel Drug Delivery Systems Market - Global Forecast 2026-2032

Cell & Gene Therapy Drug Delivery Devices Market - Global Forecast 2026-2032

Drug and Gene Delivery Devices Market Report 2025

Pharmaceutical Drug Delivery Market Outlook 2025-2034: Market Share, and Growth Analysis

Advanced Drug Delivery Systems - A Global Market Overview

About the Drug and Gene Delivery Market